Implementation of the Alzheimer’s Blood‐based Biomarker Panel in Clinical Practice: the Development of Cutoffs for Plasma Abeta1‐42/1‐40, P‐tau181, GFAP and NfL Across the Clinical Continuum
Alzheimer's & Dementia(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要